{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:08:40Z","timestamp":1794287320642,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503652"],"award-info":[{"award-number":["82503652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573856"],"award-info":[{"award-number":["82573856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the China \u201c111 Center\u201d"},{"name":"the Key R&D Program of Shandong Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,3,28]]},"DOI":"10.1038\/s41388-026-03715-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:36:35Z","timestamp":1772454995000},"page":"1026-1041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The multifunctional RNA helicase DDX39A drives glioblastoma progression by modulating WISP1 alternative splicing that induces an immunosuppressive macrophage polarization"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3389-4055","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanZhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchen","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-0211","authenticated-orcid":false,"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Bjerkvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0944-7648","authenticated-orcid":false,"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-5227","authenticated-orcid":false,"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-5040","authenticated-orcid":false,"given":"Donghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"3715_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"3715_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3715_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"3715_CR4","doi-asserted-by":"crossref","unstructured":"Gui Y, Qin H, Zhang X, Chen Q, Ye F, Tian G, et al. Glioma-Astrocyte connexin43 confers temozolomide resistance through activation of the E2F1\/ERCC1 axis. Neuro-Oncology. 2024.","DOI":"10.1093\/neuonc\/noae237"},{"key":"3715_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature08909","volume":"463","author":"TW Nilsen","year":"2010","unstructured":"Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463:457\u201363.","journal-title":"Nature"},{"key":"3715_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cell.2010.11.056","volume":"144","author":"RF Luco","year":"2011","unstructured":"Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T. Epigenetics in alternative pre-mRNA splicing. Cell. 2011;144:16\u201326.","journal-title":"Cell"},{"key":"3715_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fmolb.2018.00012","volume":"5","author":"CH Su","year":"2018","unstructured":"Su CH, D D, Tarn WY. Alternative splicing in neurogenesis and brain development. Front Mol Biosci. 2018;5:12.","journal-title":"Front Mol Biosci"},{"key":"3715_CR8","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1038\/s44318-024-00262-7","volume":"43","author":"N Cho","year":"2024","unstructured":"Cho N, Kim SY, Lee SG, Park C, Choi S, Kim EM, et al. Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer. EMBO J. 2024;43:5421\u201344.","journal-title":"EMBO J"},{"key":"3715_CR9","doi-asserted-by":"crossref","unstructured":"Jia Q, Sun X, Li H, Guo J, Niu K, Chan KM, et al. Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges. Gut. 2024.","DOI":"10.1136\/gutjnl-2024-333127"},{"key":"3715_CR10","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.7150\/thno.113312","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang X, Li J, Zhang C, Guan X, Li X, Jia W, et al. Old players and new insights: unraveling the role of RNA-binding proteins in brain tumors. Theranostics. 2025;15:5238\u201357.","journal-title":"Theranostics"},{"key":"3715_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-024-03053-4","volume":"43","author":"T Xu","year":"2024","unstructured":"Xu T, Li X, Zhao W, Wang X, Jin L, Feng Z, et al. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis. J Exp Clin Cancer Res. 2024;43:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"3715_CR12","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/neuonc\/noab126","volume":"23","author":"Y Li","year":"2021","unstructured":"Li Y, Wang X, Qi S, Gao L, Huang G, Ren Z, et al. Spliceosome-regulated RSRP1-dependent NF-\u03baB activation promotes the glioblastoma mesenchymal phenotype. Neuro Oncol. 2021;23:1693\u2013708.","journal-title":"Neuro Oncol"},{"key":"3715_CR13","doi-asserted-by":"crossref","unstructured":"Liu S, Zhang S, Zhao H, Liu Y, Zhang Z, Geng X, et al. The RNA-binding protein DDX39B promotes colorectal adenocarcinoma progression by stabilizing DCLK1. Hum Mol Genet. 2025.","DOI":"10.1093\/hmg\/ddaf110"},{"key":"3715_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI120279","volume":"129","author":"X Zhou","year":"2019","unstructured":"Zhou X, Wang R, Li X, Yu L, Hua D, Sun C, et al. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B. J Clin Investig. 2019;129:676\u201393.","journal-title":"J Clin Investig"},{"key":"3715_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado4274","volume":"10","author":"Y Shi","year":"2024","unstructured":"Shi Y, Zhang W, Jia Q, Zhong X, Iyer P, Wu H, et al. Cancer-associated SF3B1-K700E mutation controls immune responses by regulating T(reg) function via aberrant Anapc13 splicing. Sci Adv. 2024;10:eado4274.","journal-title":"Sci Adv"},{"key":"3715_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn4306","volume":"10","author":"X Wang","year":"2024","unstructured":"Wang X, Sun Q, Liu T, Lu H, Lin X, Wang W, et al. Single-cell multi-omics sequencing uncovers region-specific plasticity of glioblastoma for complementary therapeutic targeting. Sci Adv. 2024;10:eadn4306.","journal-title":"Sci Adv"},{"key":"3715_CR17","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/neuonc\/noaf075","volume":"27","author":"Z Xue","year":"2025","unstructured":"Xue Z, Zhang X, Mao B, Mu G, Zhang Y, Liu J, et al. Dual role of WNT10A in promoting the malignancy of glioblastoma and remodeling the tumor microenvironment. Neuro Oncol. 2025;27:2232\u201349.","journal-title":"Neuro Oncol"},{"key":"3715_CR18","first-page":"4071","volume":"46","author":"R Bjerkvig","year":"1986","unstructured":"Bjerkvig R, Laerum OD, Mella O. Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res. 1986;46:4071\u20139.","journal-title":"Cancer Res"},{"key":"3715_CR19","doi-asserted-by":"crossref","unstructured":"Wang X, Han M, Wang S, Sun Y, Zhao W, Xue Z, et al. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention. Theranostics 2022;11:5451-69","DOI":"10.7150\/thno.72248"},{"key":"3715_CR20","doi-asserted-by":"crossref","unstructured":"Liu S, Zhang H, Li Y, Zhang Y, Bian Y, Zeng Y, et al. S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2021-002548"},{"key":"3715_CR21","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.7150\/ijbs.98529","volume":"20","author":"T Liu","year":"2024","unstructured":"Liu T, Zhang X, Yan X, Cheng L, Yan X, Zeng F, et al. Smad4 deficiency in S100A4(+) macrophages enhances colitis-associated tumorigenesis by promoting macrophage lipid metabolism augmented M2 polarization. Int J Biol Sci. 2024;20:6114\u201329.","journal-title":"Int J Biol Sci"},{"key":"3715_CR22","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1093\/nar\/gkae431","volume":"52","author":"S Banerjee","year":"2024","unstructured":"Banerjee S, Nagasawa CK, Widen SG, Garcia-Blanco MA. Parsing the roles of DExD-box proteins DDX39A and DDX39B in alternative RNA splicing. Nucleic acids Res. 2024;52:8534\u201351.","journal-title":"Nucleic acids Res"},{"key":"3715_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-022-00827-7","volume":"8","author":"H Zhang","year":"2022","unstructured":"Zhang H, He C, Guo X, Fang Y, Lai Q, Wang X, et al. DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6\/CCND1. Cell Death Discov. 2022;8:30.","journal-title":"Cell Death Discov"},{"key":"3715_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fgene.2020.00502","volume":"11","author":"X Liao","year":"2020","unstructured":"Liao X, Bu Y, Xu Z, Jia F, Chang F, Liang J, et al. WISP1 predicts clinical prognosis and is associated with tumor purity, immunocyte infiltration, and macrophage M2 polarization in pan-cancer. Front Genet. 2020;11:502.","journal-title":"Front Genet"},{"key":"3715_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16827-z","volume":"11","author":"W Tao","year":"2020","unstructured":"Tao W, Chu C, Zhou W, Huang Z, Zhai K, Fang X, et al. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma. Nat Commun. 2020;11:3015.","journal-title":"Nat Commun"},{"key":"3715_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3892\/ijo.2017.4119","volume":"51","author":"D Jing","year":"2017","unstructured":"Jing D, Zhang Q, Yu H, Zhao Y, Shen L. Identification of WISP1 as a novel oncogene in glioblastoma. Int J Oncol. 2017;51:1261\u201370.","journal-title":"Int J Oncol"},{"key":"3715_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105295","volume":"163","author":"Y Xia","year":"2021","unstructured":"Xia Y, Xu F, Xiong M, Yang H, Lin W, Xie Y, et al. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharmacol Res. 2021;163:105295.","journal-title":"Pharmacol Res"},{"key":"3715_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10585-023-10202-0","volume":"40","author":"H Xi","year":"2023","unstructured":"Xi H, Wu M, Ma H, Li S, Huang Q, Zhang Y, et al. Repurposing fluphenazine to suppress melanoma brain, lung and bone metastasis by inducing G0\/G1 cell cycle arrest and apoptosis and disrupting autophagic flux. Clin Exp Metastasis. 2023;40:161\u201375.","journal-title":"Clin Exp Metastasis"},{"key":"3715_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41419-024-06779-3","volume":"15","author":"JR Jacob","year":"2024","unstructured":"Jacob JR, Palanichamy K, Chakravarti A. Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN. Cell Death Dis. 2024;15:414.","journal-title":"Cell Death Dis"},{"key":"3715_CR30","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1016\/j.molcel.2023.10.008","volume":"83","author":"I Tapescu","year":"2023","unstructured":"Tapescu I, Taschuk F, Pokharel SM, Zginnyk O, Ferretti M, Bailer PF, et al. The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection. Mol Cell. 2023;83:4174\u201389.e7.","journal-title":"Mol Cell"},{"key":"3715_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403387","volume":"11","author":"C Chang","year":"2024","unstructured":"Chang C, Li L, Su L, Yang F, Zha Q, Sun M, et al. Intron retention of DDX39A driven by SNRPD2 is a crucial splicing axis for oncogenic MYC\/spliceosome program in hepatocellular carcinoma. Adv Sci. 2024;11:e2403387.","journal-title":"Adv Sci"},{"key":"3715_CR32","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1093\/nar\/gkae622","volume":"52","author":"I Taniguchi","year":"2024","unstructured":"Taniguchi I, Hirose T, Ohno M. The RNA helicase DDX39 contributes to the nuclear export of spliceosomal U snRNA by loading of PHAX onto RNA. Nucleic Acids Res. 2024;52:10668\u201382.","journal-title":"Nucleic Acids Res"},{"key":"3715_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.molcel.2024.11.029","volume":"85","author":"Z Xu","year":"2025","unstructured":"Xu Z, Nie C, Liao J, Ma Y, Zhou XA, Li X, et al. DDX39A resolves replication fork-associated RNA-DNA hybrids to balance fork protection and cleavage for genomic stability maintenance. Mol Cell. 2025;85:490\u2013505.e11.","journal-title":"Mol Cell"},{"key":"3715_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13130-8","volume":"24","author":"L Liu","year":"2024","unstructured":"Liu L, Wang P, Guo C, Song L, Chen L, Qi H, et al. TRAIP enhances progression of tongue squamous cell carcinoma through EMT and Wnt\/\u03b2-catenin signaling by interacting with DDX39A. BMC Cancer. 2024;24:1481.","journal-title":"BMC Cancer"},{"key":"3715_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4161\/cbt.6.6.4192","volume":"6","author":"T Sugiura","year":"2007","unstructured":"Sugiura T, Nagano Y, Noguchi Y. DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth. Cancer Biol Ther. 2007;6:957\u201364.","journal-title":"Cancer Biol Ther"},{"key":"3715_CR36","doi-asserted-by":"crossref","unstructured":"Li Y, Chen Z, Gao Y, Liu Y, Gao Q, Pu Y, et al. SNRPB-mediated regulation of DDX39A splicing promotes ovarian cancer progression by regulating \u03b16 integrin subunit expression. Oncogene. 2025.","DOI":"10.1038\/s41388-025-03386-0"},{"key":"3715_CR37","doi-asserted-by":"publisher","first-page":"117293","DOI":"10.1016\/j.biopha.2024.117293","volume":"178","author":"X Zhang","year":"2024","unstructured":"Zhang X, Shi X, Zhang X, Zhang Y, Yu S, Zhang Y, et al. Repositioning fluphenazine as a cuproptosis-dependent anti-breast cancer drug candidate based on TCGA database. Biomed Pharmacother Biomed Pharmacother. 2024;178:117293.","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"3715_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22605","volume":"9","author":"C Su","year":"2023","unstructured":"Su C, Cheng CY, Rong Z, Yang JC, Li ZM, Yao JY, et al. Repurposing fluphenazine as an autophagy modulator for treating liver cancer. Heliyon. 2023;9:e22605.","journal-title":"Heliyon"},{"key":"3715_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686809","volume":"12","author":"X Ren","year":"2021","unstructured":"Ren X, Chen X, Zhang X, Jiang S, Zhang T, Li G, et al. Immune microenvironment and response in prostate cancer using large population cohorts. Front Immunol. 2021;12:686809.","journal-title":"Front Immunol"},{"key":"3715_CR40","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.molcel.2025.02.024","volume":"85","author":"X He","year":"2025","unstructured":"He X, Chen D, Liu G, Wu Q, Zhao H, Guo D, et al. PI3K\u03b2 functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. Mol Cell. 2025;85:1411\u201325.e8.","journal-title":"Mol Cell"},{"key":"3715_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2025.126017","volume":"372","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cheng D, He J, Liu S, Wang X, Wang M. Magnolol protects C6 glioma cells against neurotoxicity of FB1 via modulating PI3K\/Akt and mitochondria-associated apoptosis signaling pathways. Environ Pollut. 2025;372:126017.","journal-title":"Environ Pollut"},{"key":"3715_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98170-1","volume":"15","author":"M Zhang","year":"2025","unstructured":"Zhang M, Li J, Meng X, Sun Q, Xue Z, Wang M, et al. ITGA5 induces mesenchymal transformation to promote gliomas progression via PI3K\/AKT\/mTORC1 signaling pathway. Sci Rep. 2025;15:13539.","journal-title":"Sci Rep"},{"key":"3715_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11097-6","volume":"23","author":"Z Xue","year":"2023","unstructured":"Xue Z, Wang J, Wang Z, Liu J, Zhao J, Liu X, et al. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway. BMC Cancer. 2023;23:589.","journal-title":"BMC Cancer"}],"updated-by":[{"DOI":"10.1038\/s41388-026-03756-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03715-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03715-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03715-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:36:32Z","timestamp":1775108192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03715-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,3,28]]}},"alternative-id":["3715"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03715-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the Fig 3 legend, in the sentence beginning 'Numbered annotations...', the values '[4, 8, 11, 12, 36, 40] ' should have read '[12, 4, 11, 39, 8, 35]'. These numbers refer to exon positions.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-026-03756-2","URL":"https:\/\/doi.org\/10.1038\/s41388-026-03756-2","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}